| 摘要 |
The invention relates to novel polyethylene glycol (PEG) based prodrug of Adrenomedullin, to processes for preparation thereof, to the use thereof for treatment and/or prevention of diseases, and to the use thereof for producing medicaments for treatment and/or prevention of diseases, especially of cardiovascular, edematous and/or inflammatory disorders. |
| 申请人 |
BAYER PHARMA AKTIENGESELLSCHAFT;BAYER INTELLECTUAL PROPERTY GMBH |
发明人 |
FLAMME, INGO;KOBBERLING, JOHANNES;LERCHEN, HANS-GEORG;GRIEBENOW, NILS;SCHOHE-LOOP, RUDOLF;WITTROCK, SVEN;KOELLNBERGER, MARIA;WUNDER, FRANK;REDLICH, GORDEN;KNORR, ANDREAS;MARLEY, JULY;PRITCHARD, IAIN |
